Chemoinformaics analysis of luteolin 7-O-beta-D-glucoside
| Molecular Weight | 447.372 | nRot | 4 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 24 |
| Exact Molecular Weight | 447.093 | nRing | 4 |
| Solubility: LogS | -3.812 | nHRing | 2 |
| Solubility: LogP | 0.317 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 56.5611 |
| nHD | 6 | BPOL | 26.0049 |
| QED | 0.261 |
| Synth | 3.924 |
| Natural Product Likeliness | 1.972 |
| NR-PPAR-gamma | 0.932 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.895 |
| HIA | 0.864 |
| CACO-2 | -6.126 |
| MDCK | 0.0000294 |
| BBB | 0.061 |
| PPB | 0.874205 |
| VDSS | 0.879 |
| FU | 0.115906 |
| CYP1A2-inh | 0.087 |
| CYP1A2-sub | 0.048 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.205 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.059 |
| CYP3a4-sub | 0.019 |
| CL | 4.318 |
| T12 | 0.631 |
| hERG | 0.027 |
| Ames | 0.757 |
| ROA | 0.034 |
| SkinSen | 0.346 |
| Carcinogencity | 0.569 |
| EI | 0.031 |
| Respiratory | 0.061 |
| NR-Aromatase | 0.914 |
| Antiviral | Yes |
| Prediction | 0.829019 |